Income Statement Iqvia Holdings Inc.

Equities

IQV

US46266C1053

Biotechnology & Medical Research

Market Closed - Nyse Other stock markets 21:00:03 17/04/2026 BST			5-day change	1st Jan Change
176.46 ^USD	+2.62%		+5.45%	-21.72%

04-17	Lilly CEO sees weight-loss drugs reaching about half of potential users at peak	RE
04-17	Lilly's obesity pill draws 1,390 US prescriptions in launch week	RE

c8bd684a8e.ifDqG_FVa9Jlz9xSOElQG23FPISvLZ3l81R2oOBqQUs.vr3fS6EsHKQooJgYDxYCQzeaefToHvjUuz4176gjLifQyN5PniI6twv7iQ

Published financial data: IQVIA HOLDINGS INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	13.87B	14.41B	14.98B	15.4B	16.31B
Total Revenues	13.87B	14.41B	14.98B	15.4B	16.31B
Cost of Goods Sold, Total	9.23B	9.38B	9.74B	10.03B	10.88B
Gross Profit	4.64B	5.03B	5.24B	5.38B	5.43B
Selling General & Admin Expenses, Total	1.93B	2.04B	2.04B	1.98B	1.99B
Depreciation & Amortization - (IS)	1.26B	1.13B	1.12B	1.11B	1.14B
Other Operating Expenses	-	-	-	-	-
Other Operating Expenses, Total	3.2B	3.17B	3.17B	3.1B	3.13B
Operating Income	1.45B	1.86B	2.07B	2.28B	2.3B
Interest Expense, Total	-375M	-416M	-672M	-670M	-729M
Interest And Investment Income	6M	13M	36M	47M	45M
Net Interest Expenses	-369M	-403M	-636M	-623M	-684M
Income (Loss) On Equity Invest.	6M	-12M	-	5M	22M
Currency Exchange Gains (Loss)	-	-	-	-	-
Other Non Operating Income (Expenses)	38M	-54M	36M	-13M	10M
EBT, Excl. Unusual Items	1.12B	1.39B	1.47B	1.65B	1.65B
Restructuring Charges	-20M	-28M	-84M	-67M	-105M
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	16M	-27M	20M	22M	44M
Asset Writedown	-	-	-	-	-
Other Unusual Items	17M	15M	52M	71M	28M
EBT, Incl. Unusual Items	1.13B	1.35B	1.46B	1.67B	1.61B
Income Tax Expense	163M	260M	101M	301M	252M
Earnings From Continuing Operations	971M	1.09B	1.36B	1.37B	1.36B
Net Income to Company	971M	1.09B	1.36B	1.37B	1.36B
Minority Interest	-5M	-	-	-	-1M
Net Income - (IS)	966M	1.09B	1.36B	1.37B	1.36B
Net Income to Common Incl Extra Items	966M	1.09B	1.36B	1.37B	1.36B
Net Income to Common Excl. Extra Items	966M	1.09B	1.36B	1.37B	1.36B
Per Share Items
Net EPS - Basic	5.05	5.82	7.39	7.57	7.91
Basic EPS - Continuing Operations	5.05	5.82	7.39	7.57	7.91
Basic Weighted Average Shares Outstanding	191M	188M	184M	181M	172M
Net EPS - Diluted	4.95	5.72	7.29	7.49	7.84
Diluted EPS - Continuing Operations	4.95	5.72	7.29	7.49	7.84
Diluted Weighted Average Shares Outstanding	195M	191M	186M	183M	174M
Normalized Basic EPS	3.63	4.63	5	5.68	5.98
Normalized Diluted EPS	3.57	4.56	4.93	5.62	5.92
Supplemental Items
EBITDA	2.5B	2.57B	2.72B	2.92B	2.94B
EBITA	2.35B	2.41B	2.57B	2.77B	2.78B
EBIT	1.45B	1.86B	2.07B	2.28B	2.3B
EBITDAR	2.68B	2.74B	2.88B	3.08B	3.1B
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	14.37	19.24	6.92	17.98	15.62
Current Domestic Taxes	16M	24M	21M	44M	49M
Current Foreign Taxes	293M	358M	349M	386M	383M
Total Current Taxes	309M	382M	370M	430M	432M
Deferred Domestic Taxes	-106M	-94M	-236M	-116M	-132M
Deferred Foreign Taxes	-40M	-28M	-33M	-13M	-48M
Total Deferred Taxes	-146M	-122M	-269M	-129M	-180M
Normalized Net Income	696M	869M	919M	1.03B	1.03B
Non-Cash Pension Expense	-33M	-33M	-10M	-10M	-11M
Supplemental Operating Expense Items
Net Rental Expense, Total	184M	171M	160M	158M	160M
Imputed Operating Lease Interest Expense	42.88M	44.09M	63.03M	59.57M	61.26M
Imputed Operating Lease Depreciation	141M	127M	96.97M	98.43M	98.74M
Stock-Based Comp., SG&A Exp. (Total)	170M	194M	217M	206M	247M
Total Stock-Based Compensation	170M	194M	217M	206M	247M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1.37B	1.22B	1.38B	1.7B	1.98B
Short Term Investments	111M	93M	120M	141M	161M
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	1.48B	1.31B	1.5B	1.84B	2.14B
Accounts Receivable, Total	2.55B	2.92B	3.38B	3.2B	3.4B
Other Receivables	58M	43M	32M	36M	27M
Total Receivables	2.61B	2.96B	3.41B	3.24B	3.43B
Prepaid Expenses	156M	151M	141M	154M	162M
Other Current Assets, Total	521M	561M	546M	592M	519M
Total Current Assets	4.76B	4.98B	5.6B	5.83B	6.25B
Gross Property Plant And Equipment	1.67B	1.7B	1.62B	1.59B	1.73B
Accumulated Depreciation	-765M	-840M	-803M	-819M	-905M
Net Property Plant And Equipment	903M	863M	819M	773M	823M
Long-term Investments	168M	162M	239M	374M	432M
Goodwill	13.3B	13.92B	14.57B	14.71B	16.62B
Other Intangibles, Total	4.94B	4.82B	4.84B	4.5B	4.96B
Deferred Tax Assets Long-Term	124M	118M	166M	194M	357M
Other Long-Term Assets, Total	487M	472M	455M	520M	505M
Total Assets	24.69B	25.34B	26.68B	26.9B	29.94B
Liabilities
Accounts Payable, Total	621M	645M	709M	736M	780M
Accrued Expenses, Total	1.42B	1.49B	1.48B	1.42B	1.51B
Current Portion of Long-Term Debt	91M	152M	769M	1.15B	1.88B
Current Portion of Leases	149M	116M	107M	105M	99M
Current Income Taxes Payable	137M	161M	116M	156M	140M
Unearned Revenue Current, Total	2.71B	2.86B	3.11B	3.24B	3.51B
Other Current Liabilities	119M	152M	199M	153M	417M
Total Current Liabilities	5.24B	5.58B	6.49B	6.96B	8.34B
Long-Term Debt	12.06B	12.6B	12.96B	12.84B	13.88B
Long-Term Leases	490M	488M	451M	391M	437M
Pension & Other Post Retirement Benefits	231M	179M	214M	221M	239M
Deferred Tax Liability Non Current	410M	464M	202M	196M	179M
Other Non Current Liabilities	217M	268M	256M	229M	237M
Total Liabilities	18.65B	19.57B	20.57B	20.83B	23.31B
Common Stock, Total	3M	3M	3M	3M	3M
Additional Paid In Capital	10.77B	10.9B	11.02B	11.14B	11.38B
Retained Earnings	2.24B	3.33B	4.69B	6.06B	7.42B
Treasury Stock	-6.57B	-7.74B	-8.74B	-10.1B	-11.36B
Comprehensive Income and Other	-406M	-727M	-867M	-1.04B	-943M
Total Common Equity	6.04B	5.76B	6.11B	6.07B	6.5B
Minority Interest	-	-	-	-	127M
Total Equity	6.04B	5.76B	6.11B	6.07B	6.63B
Total Liabilities And Equity	24.69B	25.34B	26.68B	26.9B	29.94B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	190M	186M	182M	176M	170M
ECS Total Common Shares Outstanding	191M	186M	182M	176M	170M
Book Value / Share	31.7	31.04	33.67	34.45	38.34
Tangible Book Value	-12.2B	-12.98B	-13.29B	-13.14B	-15.08B
Tangible Book Value Per Share	-64.02	-69.88	-73.25	-74.63	-88.89
Total Debt	12.79B	13.35B	14.28B	14.48B	16.3B
Net Debt	11.31B	12.04B	12.79B	12.64B	14.16B
Debt Equivalent of Unfunded Proj. Benefit Obligation	122M	87M	94M	74M	63M
Debt Equivalent Oper. Leases	1.47B	1.37B	1.28B	1.26B	1.28B
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	127M
Equity Method Investments, Total	88M	94M	134M	266M	324M
Account Code - Inventory Valuation	3	-	-	3	3
Land - (BS)	376M	363M	376M	367M	385M
Machinery, Total	886M	1.01B	950M	987M	1.05B
Full Time Employees	79K	86K	87K	88K	93K
Accumulated Allowance for Doubtful Accounts (Supple)	33M	36M	34M	42M	51M
Order Backlog	24.8B	27.2B	29.7B	31.1B	32.7B

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	966M	1.09B	1.36B	1.37B	1.36B
Depreciation & Amortization - CF	147M	160M	151M	149M	160M
Amortization of Goodwill and Intangible Assets - (CF)	906M	551M	499M	493M	480M
Depreciation & Amortization, Total	1.05B	711M	650M	642M	640M
Amortization of Deferred Charges, Total - (CF)	228M	434M	493M	493M	527M
(Gain) Loss From Sale Of Asset	-	-10M	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-16M	27M	-20M	-22M	-44M
Asset Writedown & Restructuring Costs	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-6M	12M	-	-5M	-22M
Stock-Based Compensation (CF)	170M	194M	217M	206M	247M
Tax Benefit from Stock Options	-	-	-	-	-
Other Operating Activities, Total	-133M	-115M	-269M	-129M	-179M
Change In Accounts Receivable	-138M	-421M	-388M	182M	60M
Change In Accounts Payable	244M	427M	267M	115M	-96M
Change in Unearned Revenues	591M	31M	-29M	9M	242M
Change In Income Taxes	-2M	-128M	-164M	-155M	-299M
Change in Other Net Operating Assets	-15M	7M	34M	7M	218M
Cash from Operations	2.94B	2.26B	2.15B	2.72B	2.65B
Capital Expenditure	-640M	-674M	-649M	-602M	-603M
Sale of Property, Plant, and Equipment	-	-	-	25M	75M
Cash Acquisitions	-1.46B	-1.32B	-876M	-735M	-1.71B
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-10M	-25M	-83M	-134M	-62M
Other Investing Activities, Total	5M	8M	5M	2M	-1M
Cash from Investing	-2.1B	-2.01B	-1.6B	-1.44B	-2.3B
Long-Term Debt Issued, Total	2.76B	3.6B	6.38B	1.68B	9.84B
Total Debt Issued	2.76B	3.6B	6.38B	1.68B	9.84B
Long-Term Debt Repaid, Total	-2.69B	-2.66B	-5.58B	-1.13B	-8.59B
Total Debt Repaid	-2.69B	-2.66B	-5.58B	-1.13B	-8.59B
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-406M	-1.17B	-992M	-1.35B	-1.24B
Other Financing Activities, Total	-899M	-102M	-192M	-81M	-153M
Cash from Financing	-1.24B	-329M	-382M	-878M	-150M
Foreign Exchange Rate Adjustments	-52M	-75M	-4M	-68M	79M
Net Change in Cash	-448M	-150M	160M	326M	278M
Supplemental Items
Cash Interest Paid	343M	379M	-	-	-
Cash Income Tax Paid (Refund)	222M	255M	340M	295M	395M
Levered Free Cash Flow	1.97B	1.37B	1.35B	1.84B	2.22B
Unlevered Free Cash Flow	2.19B	1.61B	1.75B	2.24B	2.65B
Change In Net Working Capital	-494M	202M	239M	-94M	-425M
Net Debt Issued / Repaid	70M	941M	802M	553M	1.25B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.67	4.65	4.98	5.32	5.05
Return on Total Capital	4.75	6.18	6.61	7.01	6.66
Return On Equity %	15.76	18.48	22.87	22.55	21.44
Return on Common Equity	16.04	18.48	22.87	22.55	21.64
Margin Analysis
Gross Profit Margin %	33.45	34.89	34.96	34.89	33.29
SG&A Margin	13.92	14.14	13.63	12.87	12.19
EBITDA Margin %	18.01	17.84	18.16	18.96	18.01
EBITA Margin %	16.95	16.73	17.15	17.99	17.03
EBIT Margin %	10.42	12.91	13.82	14.79	14.09
Income From Continuing Operations Margin %	7	7.57	9.06	8.91	8.34
Net Income Margin %	6.96	7.57	9.06	8.91	8.34
Net Avail. For Common Margin %	6.96	7.57	9.06	8.91	8.34
Normalized Net Income Margin	5.01	6.03	6.14	6.69	6.3
Levered Free Cash Flow Margin	14.23	9.48	8.99	11.94	13.59
Unlevered Free Cash Flow Margin	15.8	11.18	11.67	14.52	16.24
Asset Turnover
Asset Turnover	0.56	0.58	0.58	0.58	0.57
Fixed Assets Turnover	14.95	16.32	17.82	19.35	20.44
Receivables Turnover (Average Receivables)	5.59	5.27	4.76	4.68	4.94
Short Term Liquidity
Current Ratio	0.91	0.89	0.86	0.84	0.75
Quick Ratio	0.78	0.77	0.76	0.73	0.67
Operating Cash Flow to Current Liabilities	0.56	0.41	0.33	0.39	0.32
Days Sales Outstanding (Average Receivables)	65.26	69.25	76.71	78.22	73.89
Average Days Payable Outstanding	23.76	24.63	25.36	26.36	25.43
Long Term Solvency
Total Debt/Equity	211.65	231.59	233.67	238.73	245.93
Total Debt / Total Capital	67.91	69.84	70.03	70.48	71.09
LT Debt/Equity	207.68	226.94	219.34	218.05	216
Long-Term Debt / Total Capital	66.64	68.44	65.74	64.37	62.44
Total Liabilities / Total Assets	75.53	77.25	77.09	77.45	77.86
EBIT / Interest Expense	3.86	4.47	3.08	3.4	3.15
EBITDA / Interest Expense	7.15	6.59	4.29	4.6	4.25
(EBITDA - Capex) / Interest Expense	5.45	4.97	3.32	3.7	3.42
Total Debt / EBITDA	4.77	4.87	4.96	4.7	5.26
Net Debt / EBITDA	4.22	4.39	4.44	4.11	4.57
Total Debt / (EBITDA - Capex)	6.26	6.46	6.4	5.85	6.54
Net Debt / (EBITDA - Capex)	5.54	5.82	5.73	5.1	5.68
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	22.14	3.86	3.98	2.81	5.87
Gross Profit, 1 Yr. Growth %	20.26	8.34	4.2	2.6	1.02
EBITDA, 1 Yr. Growth %	36.56	2.88	5.83	7.35	0.58
EBITA, 1 Yr. Growth %	38.68	2.51	6.59	7.86	0.22
EBIT, 1 Yr. Growth %	78.52	28.63	11.34	10.04	0.83
Earnings From Cont. Operations, 1 Yr. Growth %	215.26	12.36	24.47	1.1	-0.87
Net Income, 1 Yr. Growth %	246.24	12.94	24.47	1.1	-0.95
Normalized Net Income, 1 Yr. Growth %	213.87	24.98	5.75	12.03	-0.22
Diluted EPS Before Extra, 1 Yr. Growth %	246.15	15.56	27.45	2.74	4.67
Accounts Receivable, 1 Yr. Growth %	5.85	14.35	15.91	-5.24	6.12
Net Property, Plant and Equip., 1 Yr. Growth %	-5.25	-4.43	-5.1	-5.62	6.47
Total Assets, 1 Yr. Growth %	0.51	2.62	5.3	0.82	11.32
Tangible Book Value, 1 Yr. Growth %	2.9	6.34	2.45	-1.14	14.71
Common Equity, 1 Yr. Growth %	0.68	-4.58	6.02	-0.74	7.19
Cash From Operations, 1 Yr. Growth %	50.18	-23.18	-4.91	26.38	-2.28
Capital Expenditures, 1 Yr. Growth %	3.9	5.31	-3.71	-7.24	0.17
Levered Free Cash Flow, 1 Yr. Growth %	20.89	-34.96	-9.12	26.51	14.05
Unlevered Free Cash Flow, 1 Yr. Growth %	16.88	-30.48	1.27	20.53	13.15
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	11.86	12.63	3.92	3.39	4.33
Gross Profit, 2 Yr. CAGR %	10.69	14.15	6.25	3.39	1.81
EBITDA, 2 Yr. CAGR %	15.26	18.53	4.35	6.59	3.91
EBITA, 2 Yr. CAGR %	15.83	19.23	4.53	7.23	3.97
EBIT, 2 Yr. CAGR %	28.55	51.54	19.68	10.69	5.34
Earnings From Cont. Operations, 2 Yr. CAGR %	106.82	88.21	18.26	12.18	0.11
Net Income, 2 Yr. CAGR %	124.89	97.75	18.57	12.18	0.07
Normalized Net Income, 2 Yr. CAGR %	81.62	98.06	14.96	8.85	5.73
Diluted EPS Before Extra, 2 Yr. CAGR %	127.07	100	21.36	14.43	3.7
Accounts Receivable, 2 Yr. CAGR %	-0.6	10.02	15.12	4.8	0.28
Net Property, Plant and Equip., 2 Yr. CAGR %	-2.71	-4.84	-4.76	-5.36	0.24
Total Assets, 2 Yr. CAGR %	3.05	1.56	3.96	3.04	5.94
Tangible Book Value, 2 Yr. CAGR %	2.25	4.61	4.38	0.64	6.49
Common Equity, 2 Yr. CAGR %	0.32	-1.99	0.58	2.59	3.15
Cash From Operations, 2 Yr. CAGR %	44.09	7.41	-14.53	9.63	11.13
Capital Expenditures, 2 Yr. CAGR %	4.86	4.6	0.7	-5.49	-3.61
Levered Free Cash Flow, 2 Yr. CAGR %	30.1	-8.56	-19.92	11.4	23.5
Unlevered Free Cash Flow, 2 Yr. CAGR %	23.68	-7.33	-13.13	13.81	19.49
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	10.04	9.13	9.67	3.55	4.21
Gross Profit, 3 Yr. CAGR %	8.18	9.9	10.73	5.02	2.6
EBITDA, 3 Yr. CAGR %	11.66	10.98	14.14	5.34	4.55
EBITA, 3 Yr. CAGR %	12.09	11.21	14.86	5.63	4.84
EBIT, 3 Yr. CAGR %	20.18	28.58	36.74	16.37	7.3
Earnings From Cont. Operations, 3 Yr. CAGR %	50.65	68.76	63.98	12.24	7.65
Net Income, 3 Yr. CAGR %	55.08	78.76	69.47	12.43	7.62
Normalized Net Income, 3 Yr. CAGR %	40.53	60.35	60.68	13.98	5.74
Diluted EPS Before Extra, 3 Yr. CAGR %	58.63	81.29	72.11	14.8	11.08
Accounts Receivable, 3 Yr. CAGR %	2.14	4.15	11.95	7.89	5.24
Net Property, Plant and Equip., 3 Yr. CAGR %	27.66	-3.29	-4.93	-5.05	-1.57
Total Assets, 3 Yr. CAGR %	3.07	2.91	2.79	2.9	5.73
Tangible Book Value, 3 Yr. CAGR %	3.4	3.6	3.88	2.5	5.12
Common Equity, 3 Yr. CAGR %	-3.45	-1.34	0.61	0.14	4.1
Cash From Operations, 3 Yr. CAGR %	32.88	16.84	3.13	-2.63	5.5
Capital Expenditures, 3 Yr. CAGR %	11.72	5.01	1.75	-2.02	-3.64
Levered Free Cash Flow, 3 Yr. CAGR %	22.97	5.39	-6.24	-4.32	14.37
Unlevered Free Cash Flow, 3 Yr. CAGR %	18.73	3.97	-2.31	-1.17	15.34
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	15.28	8.23	7.55	6.8	7.5
Gross Profit, 5 Yr. CAGR %	17.56	8.13	7.4	7.25	7.07
EBITDA, 5 Yr. CAGR %	19.86	9.12	8.68	9.2	9.93
EBITA, 5 Yr. CAGR %	20.36	9.42	9	9.6	10.37
EBIT, 5 Yr. CAGR %	13.58	18.83	19.98	21.1	23.19
Earnings From Cont. Operations, 5 Yr. CAGR %	62.01	-3.39	36.75	43.33	34.61
Net Income, 5 Yr. CAGR %	68.08	-3.1	39.29	48.36	37.27
Normalized Net Income, 5 Yr. CAGR %	13.5	29.25	29.69	37.33	35.91
Diluted EPS Before Extra, 5 Yr. CAGR %	60.14	-0.07	42.52	50.81	40.54
Accounts Receivable, 5 Yr. CAGR %	8.37	6.82	7.15	4.41	7.13
Net Property, Plant and Equip., 5 Yr. CAGR %	17.34	14.42	13.54	-4.12	-2.89
Total Assets, 5 Yr. CAGR %	3.09	2.08	3.42	2.96	4.04
Tangible Book Value, 5 Yr. CAGR %	7.54	4.43	3.79	2.4	4.92
Common Equity, 5 Yr. CAGR %	-6.89	-6.33	-1.86	0.21	1.62
Cash From Operations, 5 Yr. CAGR %	27.89	18.43	11.38	13.9	6.26
Capital Expenditures, 5 Yr. CAGR %	31.3	12.8	7.17	0.68	-0.43
Levered Free Cash Flow, 5 Yr. CAGR %	13.83	5.98	4.86	9.53	6.3
Unlevered Free Cash Flow, 5 Yr. CAGR %	14.93	5.56	5.95	9.31	7.16